Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate.

Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate.

Omicron subvariants of SARS-CoV-2 continue to pose a significant global health threat. Nanobodies, single-domain antibodies derived from camelids, are promising therapeutic tools against pandemic viruses due to their favorable properties. In this study, we identified a novel nanobody, Nanosota-9, wh...

Full description

Saved in:
Bibliographic Details
Main Authors: Gang Ye, Fan Bu, Divyasha Saxena, Hailey Turner-Hubbard, Morgan Herbst, Benjamin Spiller, Brian E Wadzinski, Lanying Du, Bin Liu, Jian Zheng, Fang Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-11-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1012726
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items